skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Journal of the American College of Cardiology, 2022-05, Vol.79 (17), p.1757-1780
[Peer Reviewed Journal]
2022 The Authors ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.011
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Author:
Heidenreich, Paul A.
;
Bozkurt, Biykem
;
Aguilar, David
;
Allen, Larry A.
;
Byun, Joni J.
;
Colvin, Monica M.
;
Deswal, Anita
;
Drazner, Mark H.
;
Dunlay, Shannon M.
;
Evers, Linda R.
;
Fang, James C.
;
Fedson, Savitri E.
;
Fonarow, Gregg C.
;
Hayek, Salim S.
;
Hernandez, Adrian F.
;
Khazanie, Prateeti
;
Kittleson, Michelle M.
;
Lee, Christopher S.
;
Link, Mark S.
;
Milano, Carmelo A.
;
Nnacheta, Lorraine C.
;
Sandhu, Alexander T.
;
Stevenson, Lynne Warner
;
Vardeny, Orly
;
Vest, Amanda R.
;
Yancy, Clyde W.
Subjects:
ACC/AHA Clinical Practice Guidelines
;
ACE inhibitors
;
acute decompensated heart failure
;
angiotensin and neprilysin receptor antagonist
;
angiotensin receptor antagonist
;
atrial fibrillation
;
beta blockers
;
cardiac amyloidosis
;
cardiac failure
;
cardio-oncology
;
cardiogenic shock
;
cardiomyopathy
;
cardiomyopathy in pregnancy
;
chronic heart failure
;
congestive heart failure
;
diabetes
;
guideline-directed medical therapy
;
heart failure
;
heart failure rehabilitation
;
heart failure with mildly reduced ejection fraction
;
heart failure with preserved ejection fraction
;
heart failure with reduced ejection fraction
;
mineralocorticoid receptor antagonists
;
mitral regurgitation
;
palliative care
;
reduced ejection fraction
;
right heart pressure
;
sacubitrilvalsartan
;
SGLT2 inhibitors
;
social determinants of health
;
sodium glucose co-transporter 2
;
systolic heart failure
;
valvular heart disease
Is Part Of:
Journal of the American College of Cardiology, 2022-05, Vol.79 (17), p.1757-1780
Description:
The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.” The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021. Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients’ interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.
Publisher:
Elsevier Inc
Language:
English
Identifier:
ISSN: 0735-1097
EISSN: 1558-3597
DOI: 10.1016/j.jacc.2021.12.011
Source:
GFMER Free Medical Journals
Alma/SFX Local Collection
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript